Group One Trading, L.P. Spruce Biosciences, Inc. Transaction History
Group One Trading, L.P.
- $2.4 Billion
- Q3 2024
A detailed history of Group One Trading, L.P. transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 3,839 shares of SPRB stock, worth $1,420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,839
Previous 3,839
-0.0%
Holding current value
$1,420
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SPRB
# of Institutions
34Shares Held
15.4MCall Options Held
16.7KPut Options Held
1.1K-
River Vest Venture Management LLC St. Louis, MO2.94MShares$1.09 Million20.39% of portfolio
-
Carlyle Group Inc. Washington, DC2.9MShares$1.07 Million0.2% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.61MShares$965,3760.04% of portfolio
-
Abingworth LLP London, X01.79MShares$663,2310.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.26MShares$465,8850.0% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $8.72M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...